
With regard to adding Pyridoxal Phosphate (PALP), which combines with the active sites of AST and ALT, JSCC recommends measuring holoenzymes without adding PALP, reflecting the biological reaction. On the other hand, IFCC recommends the measurement of both holoenzymes and apoenzymes when PALP is added, reflecting the total diverted from the internal organs. It is important which recommendation to follow from a clinical point of view and from the viewpoint of reducing gaps in clinical facilities. Further, it is necessary to consider each isozyme as well as the time difference between apoenzyme and holoenzyme diversion from blood to accurately grasp the pathology and understand the measurement.
Biliary Tract Diseases, Liver Diseases, Myocardial Infarction, Alanine Transaminase, Clinical Enzyme Tests, Muscular Dystrophies, Isoenzymes, Apoenzymes, Pyridoxal Phosphate, Humans, Aspartate Aminotransferases, Holoenzymes, Biomarkers
Biliary Tract Diseases, Liver Diseases, Myocardial Infarction, Alanine Transaminase, Clinical Enzyme Tests, Muscular Dystrophies, Isoenzymes, Apoenzymes, Pyridoxal Phosphate, Humans, Aspartate Aminotransferases, Holoenzymes, Biomarkers
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
